Emerging cancer therapies: targeting physiological networks and cellular bioelectrical differences with non-thermal systemic electromagnetic fields in the human body - a comprehensive review

Abstract

Overview

A steadily increasing number of publications support the concept of physiological networks, and how cellular bioelectrical properties drive cell proliferation and cell synchronization. All cells, especially cancer cells, are known to possess characteristic electrical properties critical for physiological behavior, with major differences between normal and cancer cell counterparts. This opportunity can be explored as a novel treatment modality in Oncology.

Key Points

• ✔️ Cancer cells exhibit autonomous oscillations that deviate from normal cell rhythms.
• ✔️ A dynamic approach is needed to understand cellular metabolism, gene expression, cell signaling, and membrane polarization as interconnected states in constant flux.
• ✔️ Major differences in bioelectrical activity between healthy and cancerous cells present therapeutic targets.

Findings

In oncology, radiofrequency electromagnetic fields have produced sustained responses and improved quality of life in cancer patients with minimal side effects. Non-thermal systemic radiofrequency electromagnetic fields have been shown to deliver promising therapeutic responses at both cellular and tissue levels in humans.

Conclusion

This comprehensive review supports non-thermal systemic electromagnetic fields as a promising and emerging cancer treatment modality, with early clinical experiences showing favorable outcomes, particularly in advanced cancer. It is important to be aware of the interplay between EMF exposure and physiological effects, supporting the connection between EMFs and health risks, especially in cancer.